Dennis Talbot

779 total citations
6 papers, 595 citations indexed

About

Dennis Talbot is a scholar working on Oncology, Molecular Biology and Surgery. According to data from OpenAlex, Dennis Talbot has authored 6 papers receiving a total of 595 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Oncology, 2 papers in Molecular Biology and 1 paper in Surgery. Recurrent topics in Dennis Talbot's work include PI3K/AKT/mTOR signaling in cancer (2 papers), Protein Kinase Regulation and GTPase Signaling (1 paper) and Radiopharmaceutical Chemistry and Applications (1 paper). Dennis Talbot is often cited by papers focused on PI3K/AKT/mTOR signaling in cancer (2 papers), Protein Kinase Regulation and GTPase Signaling (1 paper) and Radiopharmaceutical Chemistry and Applications (1 paper). Dennis Talbot collaborates with scholars based in United Kingdom, Italy and Switzerland. Dennis Talbot's co-authors include Mohammed Kalan, W.J. Cunliffe, Trivadi S. Ganesan, Adrian L. Harris, Frances R. Balkwill, P. Thavasu, David Propper, Francesco Caponigro, P. A. Philip and N Stuart and has published in prestigious journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and International Journal of Gynecological Cancer.

In The Last Decade

Dennis Talbot

6 papers receiving 566 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Dennis Talbot United Kingdom	5	196	191	162	135	120	6	595
Jérôme Rollin France	8	31 0.2×	196 1.0×	125 0.8×	167 1.2×	68 0.6×	12	468
Miguel H. Bronchud Spain	11	38 0.2×	126 0.7×	34 0.2×	129 1.0×	327 2.7×	33	574
S Kuriya Japan	13	33 0.2×	93 0.5×	47 0.3×	423 3.1×	65 0.5×	51	567
Keith F. Izban United States	14	20 0.1×	282 1.5×	45 0.3×	60 0.4×	151 1.3×	19	577
Mohammad R. Nowrousian Germany	15	16 0.1×	245 1.3×	40 0.2×	359 2.7×	237 2.0×	31	693
T Kubo Japan	11	22 0.1×	90 0.5×	32 0.2×	206 1.5×	108 0.9×	17	473
Laurie Gashin United States	6	12 0.1×	148 0.8×	67 0.4×	121 0.9×	209 1.7×	9	527
Mauro Antimi Italy	10	25 0.1×	82 0.4×	303 1.9×	36 0.3×	273 2.3×	24	601
Nicolaos Anagnostopoulos Greece	10	25 0.1×	271 1.4×	22 0.1×	362 2.7×	252 2.1×	15	569
José M. Hernández Spain	7	17 0.1×	505 2.6×	99 0.6×	514 3.8×	316 2.6×	11	852

Countries citing papers authored by Dennis Talbot

Since Specialization

Citations

This map shows the geographic impact of Dennis Talbot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dennis Talbot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dennis Talbot more than expected).

Fields of papers citing papers by Dennis Talbot

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dennis Talbot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dennis Talbot. The network helps show where Dennis Talbot may publish in the future.

Co-authorship network of co-authors of Dennis Talbot

This figure shows the co-authorship network connecting the top 25 collaborators of Dennis Talbot. A scholar is included among the top collaborators of Dennis Talbot based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dennis Talbot. Dennis Talbot is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

1.

Preda, Veronica, et al.. (2018). Primary Ovarian Carcinoid. International Journal of Gynecological Cancer. 28(3). 466–471. 12 indexed citations

2.

Steward, W.P., Mark R. Middleton, Dennis Talbot, et al.. (2005). The use of pharmacokinetic and pharmacodynamic endpoints to determine dose of AQ4N given with radiotherapy (RT). Journal of Clinical Oncology. 23(16_suppl). 2062–2062. 2 indexed citations

3.

Propper, David, A. McDonald, A. Man, et al.. (2001). Phase I and Pharmacokinetic Study of PKC412, an Inhibitor of Protein Kinase C. Journal of Clinical Oncology. 19(5). 1485–1492. 190 indexed citations

4.

Propper, David, Alexander McDonald, Nicola Dobbs, et al.. (1999). The protein kinase C inhibitor CGP41251 suppresses cytokine release and extracellular signal-regulated kinase 2 expression in cancer patients.. PubMed. 59(16). 3980–4. 41 indexed citations

5.

Kalan, Mohammed, et al.. (1994). Evaluation of the modified Alvarado score in the diagnosis of acute appendicitis: a prospective study.. PubMed. 76(6). 418–9. 199 indexed citations

6.

Philip, P. A., Daniel Rea, P. Thavasu, et al.. (1993). Phase I Study of Bryostatin 1: Assessment of Interleukin 6 and Tumor Necrosis Factor Induction In Vivo. JNCI Journal of the National Cancer Institute. 85(22). 1812–1818. 151 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact